245 related articles for article (PubMed ID: 25301327)
21. Aromatase deficiency caused by mutation of
Li H; Fu S; Dai R; Sheng Z; Liu W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):794-800. PubMed ID: 35837780
[TBL] [Abstract][Full Text] [Related]
22. Aromatase Deficiency due to a Novel Mutation in
Unal E; Yıldırım R; Taş FF; Demir V; Onay H; Haspolat YK
J Clin Res Pediatr Endocrinol; 2018 Nov; 10(4):377-381. PubMed ID: 29553041
[TBL] [Abstract][Full Text] [Related]
23. Effects of estrogen replacement therapy on bone and glucose metabolism in a male with congenital aromatase deficiency.
Herrmann BL; Janssen OE; Hahn S; Broecker-Preuss M; Mann K
Horm Metab Res; 2005 Mar; 37(3):178-83. PubMed ID: 15824973
[TBL] [Abstract][Full Text] [Related]
24. Aromatase deficiency: A case series of 46, XX Chinese children and a systematic review of the literature.
Fan L; Zhang B; Li L; Gong C
Clin Endocrinol (Oxf); 2020 Dec; 93(6):687-695. PubMed ID: 32623730
[TBL] [Abstract][Full Text] [Related]
25. A novel compound heterozygous mutation of the aromatase gene in an adult man: reinforced evidence on the relationship between congenital oestrogen deficiency, adiposity and the metabolic syndrome.
Maffei L; Rochira V; Zirilli L; Antunez P; Aranda C; Fabre B; Simone ML; Pignatti E; Simpson ER; Houssami S; Clyne CD; Carani C
Clin Endocrinol (Oxf); 2007 Aug; 67(2):218-24. PubMed ID: 17547681
[TBL] [Abstract][Full Text] [Related]
26. A novel compound heterozygous variant in CYP19A1 resulting in aromatase deficiency with normal ovarian tissue.
Acar S; Erbaş İM; Paketçi A; Onay H; Çankaya T; Gürsoy S; Özhan B; Abacı A; Özer E; Olguner M; Böber E; Demir K
Turk J Pediatr; 2020; 62(5):826-830. PubMed ID: 33108086
[TBL] [Abstract][Full Text] [Related]
27. Characterization of a novel CYP19A1 (aromatase) R192H mutation causing virilization of a 46,XX newborn, undervirilization of the 46,XY brother, but no virilization of the mother during pregnancies.
Bouchoucha N; Samara-Boustani D; Pandey AV; Bony-Trifunovic H; Hofer G; Aigrain Y; Polak M; Flück CE
Mol Cell Endocrinol; 2014 Jun; 390(1-2):8-17. PubMed ID: 24705274
[TBL] [Abstract][Full Text] [Related]
28. Differential effects of variations in human P450 oxidoreductase on the aromatase activity of CYP19A1 polymorphisms R264C and R264H.
Parween S; DiNardo G; Baj F; Zhang C; Gilardi G; Pandey AV
J Steroid Biochem Mol Biol; 2020 Feb; 196():105507. PubMed ID: 31669572
[TBL] [Abstract][Full Text] [Related]
29. Aromatase deficiency in an Ontario Old Order Mennonite family.
Kim SY; Colaiacovo S; Dave S; Coughlin K; Langdon K; Stein R; Saleh M
J Pediatr Endocrinol Metab; 2021 Dec; 34(12):1615-1618. PubMed ID: 34348419
[TBL] [Abstract][Full Text] [Related]
30. Recognizing rare disorders: aromatase deficiency.
Jones ME; Boon WC; McInnes K; Maffei L; Carani C; Simpson ER
Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):414-21. PubMed ID: 17452968
[TBL] [Abstract][Full Text] [Related]
31. Long-term Effect of Aromatase Inhibition in Aromatase Excess Syndrome.
Binder G; Nakamura A; Schweizer R; Ogata T; Fukami M; Nagasaki K
J Clin Endocrinol Metab; 2021 Apr; 106(5):1491-1500. PubMed ID: 33513243
[TBL] [Abstract][Full Text] [Related]
32. A novel mutation in the human aromatase gene: insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatment.
Lanfranco F; Zirilli L; Baldi M; Pignatti E; Corneli G; Ghigo E; Aimaretti G; Carani C; Rochira V
Bone; 2008 Sep; 43(3):628-35. PubMed ID: 18590994
[TBL] [Abstract][Full Text] [Related]
33. Aromatase deficiency: rare cause of virilization.
Ludwikowski B; Heger S; Datz N; Richter-Unruh A; González R
Eur J Pediatr Surg; 2013 Oct; 23(5):418-22. PubMed ID: 23093430
[No Abstract] [Full Text] [Related]
34. Genetic mutations resulting in estrogen insufficiency in the male.
Simpson ER
Mol Cell Endocrinol; 1998 Oct; 145(1-2):55-9. PubMed ID: 9922099
[TBL] [Abstract][Full Text] [Related]
35. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment.
Maffei L; Murata Y; Rochira V; Tubert G; Aranda C; Vazquez M; Clyne CD; Davis S; Simpson ER; Carani C
J Clin Endocrinol Metab; 2004 Jan; 89(1):61-70. PubMed ID: 14715828
[TBL] [Abstract][Full Text] [Related]
36. Molecular Basis of CYP19A1 Deficiency in a 46,XX Patient With R550W Mutation in POR: Expanding the PORD Phenotype.
Parween S; Fernández-Cancio M; Benito-Sanz S; Camats N; Rojas Velazquez MN; López-Siguero JP; Udhane SS; Kagawa N; Flück CE; Audí L; Pandey AV
J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 32060549
[TBL] [Abstract][Full Text] [Related]
37. Skeletal effects of long-term estrogen and testosterone replacement treatment in a man with congenital aromatase deficiency: evidences of a priming effect of estrogen for sex steroids action on bone.
Rochira V; Zirilli L; Madeo B; Aranda C; Caffagni G; Fabre B; Montangero VE; Roldan EJ; Maffei L; Carani C
Bone; 2007 Jun; 40(6):1662-8. PubMed ID: 17400043
[TBL] [Abstract][Full Text] [Related]
38. Aromatase deficiency in men: a clinical perspective.
Rochira V; Carani C
Nat Rev Endocrinol; 2009 Oct; 5(10):559-68. PubMed ID: 19707181
[TBL] [Abstract][Full Text] [Related]
39. Local aromatase excess with recruitment of unusual promoters of
Deberles E; Durand I; Mittre H; Reznik Y; Morera J
J Pediatr Endocrinol Metab; 2022 Jul; 35(7):924-930. PubMed ID: 35667691
[TBL] [Abstract][Full Text] [Related]
40. Aromatase excess syndrome: identification of cryptic duplications and deletions leading to gain of function of CYP19A1 and assessment of phenotypic determinants.
Fukami M; Shozu M; Soneda S; Kato F; Inagaki A; Takagi H; Hanaki K; Kanzaki S; Ohyama K; Sano T; Nishigaki T; Yokoya S; Binder G; Horikawa R; Ogata T
J Clin Endocrinol Metab; 2011 Jun; 96(6):E1035-43. PubMed ID: 21470988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
